Thalidomide-NH-C2-PEG3-OH
CAS No. 2140807-23-2
Thalidomide-NH-C2-PEG3-OH( H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl]amino]- )
Catalog No. M28647 CAS No. 2140807-23-2
Thalidomide-NH-C2-PEG3-OH is an E3 ligase ligand-linker conjugate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 134 | In Stock |
|
| 10MG | 199 | In Stock |
|
| 25MG | 316 | In Stock |
|
| 50MG | 442 | In Stock |
|
| 100MG | 593 | In Stock |
|
| 200MG | 775 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThalidomide-NH-C2-PEG3-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionThalidomide-NH-C2-PEG3-OH is an E3 ligase ligand-linker conjugate.
-
DescriptionThalidomide-NH-C2-PEG3-OH is an E3 ligase ligand-linker conjugate.
-
In VitroXZ739, a CRBN-dependent PROTAC BCL-XL degrader with a DC50 value of 2.5 nM in MOLT-4 cells after 16 h treatment. XZ739 also induces cell death through caspase-mediated apoptosis.
-
In Vivo——
-
SynonymsH-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl]amino]-
-
PathwayOthers
-
TargetOther Targets
-
RecptorCYP4A|20-Hydroxyeicosatetraenoic acid(20-HETE) synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2140807-23-2
-
Formula Weight449.45
-
Molecular FormulaC21H27N3O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCCOCCOCCOCCNc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nakamura T, et al. Imidazole derivatives as new potent and selective 20-HETE synthase inhibitors. Bioorg Med Chem Lett. 2004 Jan 19;14(2):333-6.
molnova catalog
related products
-
D(+)-Glucuronic acid...
Glucuronic acid is a carboxylic acid and highly soluble in water. In humans glucuronic acid is often linked to toxic or poisonous substances to allow for subsequent elimination and to hormones to allow for easier transport.
-
GABAA receptor agent...
GABAA receptor agent 1 has strong anticonvulsant activity and is a high affinity ligand of GABAA receptor.
-
Denosumab
Denosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand.
Cart
sales@molnova.com